Literature DB >> 11543687

Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.

M J Robarge1, S M Husbands, A Kieltyka, R Brodbeck, A Thurkauf, A H Newman.   

Abstract

The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an attempt to design a novel class of D3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3-C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D2, D3, or D4 receptor cDNAs. D3 binding affinities ranged from K(i) = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D3/D2 selectivity of 64 and a D3/D4 selectivity of 1300. Structure-activity relationships for this class of ligands at D3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543687     DOI: 10.1021/jm010146o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

Review 1.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

2.  High-affinity and selective dopamine D₃ receptor full agonists.

Authors:  Jianyong Chen; Beth Levant; Shaomeng Wang
Journal:  Bioorg Med Chem Lett       Date:  2012-07-11       Impact factor: 2.823

3.  Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor.

Authors:  Mayako Michino; Comfort A Boateng; Prashant Donthamsetti; Hideaki Yano; Oluyomi M Bakare; Alessandro Bonifazi; Michael P Ellenberger; Thomas M Keck; Vivek Kumar; Clare Zhu; Ravi Verma; Jeffrey R Deschamps; Jonathan A Javitch; Amy Hauck Newman; Lei Shi
Journal:  J Med Chem       Date:  2017-01-05       Impact factor: 7.446

4.  Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.

Authors:  Aixiao Li; Yogesh Mishra; Maninder Malik; Qi Wang; Shihong Li; Michelle Taylor; David E Reichert; Robert R Luedtke; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2013-04-06       Impact factor: 3.641

5.  Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.

Authors:  Jianyong Chen; Gregory T Collins; Jian Zhang; Chao-Yie Yang; Beth Levant; James Woods; Shaomeng Wang
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

6.  Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.

Authors:  Michelle Taylor; Peter Grundt; Suzy A Griffin; Amy Hauck Newman; Robert R Luedtke
Journal:  Synapse       Date:  2010-03       Impact factor: 2.562

Review 7.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

8.  A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.

Authors:  Mayako Michino; Prashant Donthamsetti; Thijs Beuming; Ashwini Banala; Lihua Duan; Thomas Roux; Yang Han; Eric Trinquet; Amy Hauck Newman; Jonathan A Javitch; Lei Shi
Journal:  Mol Pharmacol       Date:  2013-09-23       Impact factor: 4.436

9.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

10.  Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66.

Authors:  Vivek Kumar; Ashwini K Banala; Erick G Garcia; Jianjing Cao; Thomas M Keck; Alessandro Bonifazi; Jeffery R Deschamps; Amy Hauck Newman
Journal:  ACS Med Chem Lett       Date:  2014-03-24       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.